Trial Profile
A phase 2 study Axicabtagene-ciloleucel in Non-Hodgkin's-lymphoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2018
Price :
$35
*
At a glance
- Drugs Axicabtagene ciloleucel (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 09 Oct 2018 New trial record